Research Article
Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia
Table 2
Characteristics of the study populations.
| Parameter | Frequency, number (%) |
| Gender | | Male | 40 (40%) | Female | 60 (60%) | Age | | <40 years | 54 (54%) | ≥40 years | 46 (46%) | Region | | Northern Thailand | 97 (97%) | Other | 3 (3%) | Comorbidities | | Cerebrovascular disease | 2 (2%) | Chronic lung disease | 4 (4%) | Chronic kidney disease | 11 (11%) | Cirrhosis | 9 (9%) | Diabetes mellitus | 11 (11%) | Dyslipidemia | 2 (2%) | Endocrine disease | 16 (16%) | Eye-ENT disease | 4 (4%) | Gynecologic disease | 4 (4%) | Heart disease | 8 (8%) | Hypertension | 7 (7%) | HBV infection | 27 (27%) | HCV infection | 12 (12%) | Malignancy | 4 (4%) | Seizure | 4 (4%) | Personal history | | Alcohol drinking | 14 (14%) | Herb use | 1 (1%) | Smoking | 4 (4%) | Thalassemia type | | Alpha-thalassemia | 54 (54%) | Hemoglobin H | 38 (38%) | Hemoglobin H/CS | 16 (16%) | Beta-thalassemia | 46 (46%) | Beta-thalassemia and HbE disease | 36 (36%) | Beta-thalassemia intermedia | 10 (10%) | Hemoglobin | | Mean hemoglobin level | 7.8 g/dL | Platelet | | Mean platelet count | 330,900/mm3 | Serum ferritin, ng/mL | | Mean ferritin | 1,563.46 ng/mL | Maximum ferritin > 800 ng/mL | 76 (76%) |
|
|
Hemoglobin H/CS: hemoglobin H with Hb constant spring.
|